News about Drug Discovery & Development

TAE Life Sciences and Stella Pharma to Commercialize BPA for BNCT Cancer Therapy

The collaboration objectives include extensive international cooperation in the development and commercialization of BNCT and BPA across the USA and Europe with clinical trials anticipated to begin in 2026.

Drug Discovery & Development | 14/11/2024 | By Aishwarya |  768

Chime Biologics and Waterstone to Advance ADC Development and Manufacturing

Through this collaboration, Chime Biologics and Waterstone will offer a comprehensive solution to the ADC developers for IND-enabling and clinical studies.

Drug Discovery & Development | 13/11/2024 | By Aishwarya |  270

Lupin Gets Tentative Approval from FDA for Raltegravir Tablets

Raltegravir Tablets USP, 600 mg are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection in adult patients and in pediatric patients weighing at least 40 kg.

Drug Discovery & Development | 11/11/2024 | By Aishwarya |  382

Huons Acquires Stake in PanGen to Expand Bio-Pharma Business

Huons will own PanGen shares through the acquisition of existing shareholders and a paid-in capital increase via third-party allocation.

Drug Discovery & Development | 08/11/2024 | By Aishwarya |  565

Acumen Pharmaceuticals Appoints New Chief Regulatory Officer and Head of Quality

Dr. Schacterle brings over 30 years of experience in regulatory affairs, quality assurance, and therapeutic development to Acumen, with a focus on diseases of the central nervous system.

Drug Discovery & Development | 07/11/2024 | By Aishwarya |  698

Duoning Biotech and Branca Bunus to Develop Transfection Reagents

Under this agreement, the two companies will collaborate on the development, optimization, and application of transfection reagents, with the goal of providing biopharmaceutical customers with innovative transfection reagents through resource sharing, thereby enhancing the efficiency of biopharmaceutical development in upstream bioprocess.

Drug Discovery & Development | 07/11/2024 | By Aishwarya |  404

Syndax Signs USD 350 Million Royalty Funding Deal with Royalty Pharma for Niktimvo

Under the terms of the agreement, Syndax received an upfront payment of USD 350 million in exchange for a 13.8 percent royalty on US net sales of Niktimvo.

Drug Discovery & Development | 06/11/2024 | By Aishwarya |  748

Formosa Pharma Signs Licensing Deal with DAVI for Clobetasol Propionate Ophthalmic Suspension

The DÁVI licensing agreement includes upfront, commercialization milestones, and sales milestones, with additional considerations throughout the term of the agreement.

Drug Discovery & Development | 04/11/2024 | By Aishwarya |  734

AbbVie and EvolveImmune to Develop Next-Gen Cancer Biotherapeutics

EvolveImmune's proprietary EVOLVE platform is designed to deliver potent, selective and integrated T-cell co-stimulation to amplify and sustain the tumor killing capacity of the T-cells.

Drug Discovery & Development | 01/11/2024 | By Aishwarya |  449

GC Biopharma Partners with Novelty Nobility to Jointly Research for Geographic Atrophy Therapies

Under the terms of the agreement, GC Biopharma and Novelty Nobility established a partnership to jointly research and develop antibody-based protein therapeutics for GA throughout all stages of the drug development lifecycle.

Drug Discovery & Development | 28/10/2024 | By Aishwarya |  319